Capricor Therapeutics’ experimental stem cell treatment for Duchenne muscular dystrophy failed to meet the primary and secondary objectives of a Phase 3 clinical trial, according to review documents released by …
Tag:
STAT+
-
-
Bristol Myers Squibb Bets on Supercomputing Bristol Myers Squibb is constructing a large-scale artificial intelligence supercomputer, a move designed to accelerate drug discovery by simulating complex biological interactions. The firm …
-
The American Diabetes Association (ADA) is facing internal scrutiny and leadership friction following the ejection of five diabetes specialists from its 84th Scientific Sessions in New Orleans this past June. …
-
The Federal Trade Commission has finalized a settlement with CVS Caremark to resolve allegations that the pharmacy benefit manager artificially inflated insulin prices. The agency estimates the agreement will reduce …
-
The Alzheimer’s Association International Conference (AAIC) has drawn 10,200 attendees from 115 countries, marking an increase of 1,700 from last year. The conference serves as a hub for researchers to …
-
German lawmakers have advanced a legislative proposal that would increase the mandatory rebate drugmakers must provide to the government for branded medicines from 7% to 15.5%. This policy, intended to …
-
U.S. Administration Targets Domestic Pharmaceutical Supply Chain Security Administration officials are intensifying efforts to bolster the U.S. pharmaceutical supply chain by pressuring industry leaders to move manufacturing of essential medications …
-
A secret shopper study published in the Journal of the American Medical Association found that nearly 50 direct-to-consumer telehealth sites prescribe GLP-1 medications for weight loss. The research, conducted by …
-
Rep. Diana DeGette’s Departure Signals Shift in House Energy and Commerce Committee Diana DeGette, a Democrat, has announced she will not seek re-election in 2026. Her departure creates a vacancy …
-
A bipartisan group of lawmakers is pressuring the U.S. Department of Health and Human Services (HHS) to intervene in an ongoing dispute between Eli Lilly and hospitals participating in a …
Newer Posts